Jiang, N <br/><br/>
Administration of a competitive NMDA antagonist MDL-100,453 reduces infarct size after permanent middle cerebral artery occlusion in rat.  [electronic resource] 

 -  Journal of the neurological sciences  Jun 1996 
 - 36-41 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-510X 
<br/><br/><label>Standard No.: </label>10.1016/0022-510x(95)00352-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Arterial Occlusive Diseases--drug therapy<br/>Brain Ischemia--drug therapy<br/>Cerebral Arteries<br/>Cerebral Infarction--drug therapy<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Excitatory Amino Acid Antagonists--pharmacology<br/>Infusions, Intravenous<br/>Male<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, N-Methyl-D-Aspartate--antagonists & inhibitors<br/>Valine--analogs & derivatives